MSN-611-Advanced Pharmacology Across The Life Span

Correct Answer: D. They should also be considered allergic to ceftriaxone

Explanation:

D. They should also be considered allergic to ceftriaxone

Patients with a known allergy to penicillin may also have cross-reactivity with cephalosporins like ceftriaxone due to their shared beta-lactam ring structure. Although the actual risk is lower than previously believed (especially with second- and third-generation cephalosporins), it is still significant in those with a history of severe or anaphylactic reactions to penicillin. Therefore, in patients with a serious penicillin allergy, ceftriaxone and other cephalosporins should be avoided or used only with caution and under close medical supervision.

Why the Other Options Are Incorrect:

A. It is generally safe to treat them with cephalosporins

This is not entirely true. While many patients with mild penicillin allergies can tolerate cephalosporins, those with a history of severe allergic reactions such as anaphylaxis may still be at risk. Cross-reactivity is more likely with first-generation cephalosporins and less so with later generations, but caution is still necessary.

B. They are most likely allergic to all antibiotics

This is incorrect. A penicillin allergy does not imply an allergy to all antibiotic classes. Many antibiotics—such as macrolides, fluoroquinolones, tetracyclines, and others—have completely different structures and mechanisms and are generally safe in penicillin-allergic patients.

C. You can assume they only had a childhood allergy to penicillins

Assumptions about childhood allergies resolving with age are not reliable in clinical practice. Some individuals retain their allergy, and some may even have more severe reactions later in life. A thorough history and, if necessary, allergy testing should be conducted rather than making assumptions.

Correct Answer: A. Diltiazem

Explanation:

Diltiazem is a calcium channel blocker (CCB) that is commonly used to treat dysrhythmias, particularly atrial fibrillation and atrial flutter, as well as supraventricular tachycardia (SVT). It works by inhibiting the influx of calcium into the heart's smooth muscle and conducting tissues, leading to decreased heart rate, decreased conduction through the atrioventricular (AV) node, and lower blood pressure. These actions make diltiazem an appropriate medication for managing dysrhythmias, particularly those originating above the ventricles.

Why the Other Options Are Incorrect:

B. Nicardipine

Nicardipine is a calcium channel blocker that primarily works on vascular smooth muscle to dilate arteries and reduce blood pressure. It is not typically used for treating dysrhythmias, as its primary effect is on blood pressure and vascular tone, rather than directly on the conduction system of the heart. While it can be used for hypertensive crises, it is not the first-line choice for dysrhythmias.

C. Amlodipine

Amlodipine is also a calcium channel blocker, but it primarily works by relaxing vascular smooth muscle, leading to vasodilation and lower blood pressure. It is primarily used for treating hypertension and angina, not for dysrhythmias. Like nicardipine, amlodipine has minimal effects on the heart's conduction system and is not appropriate for managing dysrhythmias

D. Labetalol

Labetalol is a beta-blocker and alpha-blocker, not a calcium channel blocker. While it is effective for hypertension and can help control heart rate through its beta-blocking effects, it is not a calcium channel blocker and is not typically used to treat dysrhythmias in the way that diltiazem is. It can be used in some cases for rate control, but it works through a different mechanism.

Correct Answer: D. History of DVT

Explanation:

The decision to prescribe a progestin-only pill (POP) versus a combined oral contraceptive (COC) typically depends on the patient's medical history and risk factors. A history of deep vein thrombosis (DVT) is a key factor in this decision. Progestin-only pills are generally preferred in patients who have a history of DVT, as they do not contain estrogen, which is known to increase the risk of blood clots. Estrogen in combined oral contraceptives can increase the likelihood of clot formation, particularly in individuals with a history of thrombotic events like DVT. Therefore, in this case, a progestin-only pill would be safer than a combined oral contraceptive.

Why the Other Options Are Incorrect:

A. BMI of 18

A BMI of 18 is considered to be in the underweight category. While BMI can be an important factor in medication prescribing (particularly with hormonal contraceptives), a low BMI alone does not require a change from COCs to progestin-only pills. The issue with BMI in relation to contraceptives typically arises when a woman is obese, as obesity can impact the efficacy of certain contraceptive methods, particularly COCs.

B. Allergy to sulfa

An allergy to sulfa is unrelated to the prescribing of combined oral contraceptives or progestin-only pills. Sulfa allergies typically pertain to medications like sulfonamides, and they do not affect the safety or efficacy of hormonal contraceptives, which do not contain sulfa components.

C. History of multiple sclerosis

Multiple sclerosis (MS) is not a contraindication to the use of combined oral contraceptives or progestin-only pills. In fact, hormonal contraception, including COCs, may even provide some benefit in regulating the menstrual cycle, which could help manage certain aspects of MS. However, there is no strong evidence suggesting that MS would necessitate a switch from COCs to POPs.

Correct Answer: B. Electrolyte imbalance

Explanation:

When treating a patient with IV furosemide, a loop diuretic, the most concerning side effect is the electrolyte imbalance that can result from its use. Furosemide works by increasing the excretion of sodium, potassium, chloride, and water from the kidneys, leading to diuresis. This can cause significant depletion of electrolytes, such as hypokalemia (low potassium), hyponatremia (low sodium), hypocalcemia (low calcium), and hypomagnesemia (low magnesium). These imbalances can lead to life-threatening complications such as arrhythmias, muscle weakness, or severe dehydration, making it the primary concern for the APRN when using furosemide.

Why the Other Options Are Incorrect:

A. Sexual dysfunction

While sexual dysfunction can occur as a side effect of certain medications, sexual dysfunction is not a common or primary concern when using furosemide. This side effect is more frequently associated with medications like antihypertensives, antidepressants, or certain diuretics, but it is not the primary risk when treating with IV furosemide.

C. Teratogenicity

Teratogenicity refers to the ability of a substance to cause birth defects. Furosemide is not classified as teratogenic; however, it should be used cautiously in pregnancy and is generally not recommended unless absolutely necessary. While it is important to be cautious with any medication during pregnancy, teratogenicity is not the primary concern when treating with IV furosemide, especially if the patient is not pregnant.

D. Hepatotoxicity

Hepatotoxicity refers to liver damage caused by a drug. Furosemide can cause some liver-related issues, particularly in patients with pre-existing liver disease, but it is not a common or primary concern in patients being treated with IV furosemide. The electrolyte imbalances and dehydration associated with furosemide are much more immediate concerns for the APRN.

Correct Answer: A. Inhaled corticosteroids (ICS)

Explanation:

Inhaled corticosteroids (ICS) are considered the first-line therapy for the long-term management of asthma. ICS medications work by reducing inflammation in the airways, which helps to prevent asthma symptoms, reduce the frequency of exacerbations, and improve overall lung function. ICS are highly effective in controlling asthma when used regularly, and they address the underlying inflammation that causes asthma symptoms. Common examples of ICS include fluticasone, budesonide, and beclometasone.

Why the Other Options Are Incorrect:

B. Angiotensin receptor - neprilysin inhibitor (ARNI)

Angiotensin receptor-neprilysin inhibitors (ARNI), such as sacubitril/valsartan, are primarily used in the treatment of heart failure and are not used for asthma management. They work by inhibiting the breakdown of certain peptides that regulate blood pressure and fluid balance, which has no direct role in managing asthma.

C. Theophylline

Theophylline is a methylxanthine medication that can be used for asthma management, but it is generally considered a second-line or add-on therapy due to its side effects and narrow therapeutic index. It has fallen out of favor as the preferred treatment for long-term asthma control due to the availability of inhaled corticosteroids (ICS), which are more effective and safer.

D. Long-acting beta agonist (LABA)

Long-acting beta agonists (LABAs), such as salmeterol and formoterol, are used to help control asthma symptoms by relaxing the smooth muscles of the airways. However, LABAs are generally used as an add-on therapy to ICS in asthma management, not as a first-line treatment. Monotherapy with LABAs for asthma is not recommended due to the increased risk of severe asthma exacerbations and death when used without an ICS.

Correct Answer: B. Preexposure prophylaxis (PrEP)

Explanation:

B. Preexposure prophylaxis (PrEP)

Preexposure prophylaxis (PrEP), such as the combination of tenofovir and emtricitabine (Truvada or Descovy), is used to prevent HIV infection in individuals at high risk. Regular HIV testing—every 90 days (or 3 months)—is required to ensure the patient remains HIV-negative while on PrEP. If a person acquires HIV while taking PrEP and continues the medication without knowing their status, it could lead to resistance to the components of PrEP, which are also used in HIV treatment regimens. Therefore, strict adherence to routine HIV testing is essential for safety and efficacy.

Why the Other Options Are Incorrect:

A. NRTI/NNRTI

Nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs) are used to treat individuals already diagnosed with HIV. These medications do not require routine HIV testing every 90 days since the patient is already HIV-positive and under monitoring as part of their treatment plan.

C. Protease inhibitors

Protease inhibitors are also part of antiretroviral therapy (ART) for HIV-positive individuals. Like NRTIs/NNRTIs, they are used in those already diagnosed, not for prevention, and thus routine screening for HIV is not required in the same way as for PrEP.

D. Acyclovir

Acyclovir is an antiviral medication used primarily for herpes simplex virus and varicella-zoster virus. It has no role in HIV prevention or treatment, and it does not require HIV testing as part of its monitoring.

Correct Answer: C. Fluoroquinolones

Explanation:

C. Fluoroquinolones

Fluoroquinolones, such as ciprofloxacin and levofloxacin, carry an FDA black box warning for the risk of tendonitis and tendon rupture. This serious adverse effect can occur during or even months after treatment and is more common in older adults, patients taking corticosteroids, and those with kidney, heart, or lung transplants. The mechanism is not completely understood, but fluoroquinolones are believed to interfere with collagen synthesis and tendon repair, leading to increased risk of injury, especially in the Achilles tendon.

Why the Other Options Are Incorrect:

A. Aminoglycosides

Aminoglycosides, such as gentamicin and tobramycin, are associated with nephrotoxicity and ototoxicity but do not carry a black box warning for tendon rupture.

B. Tetracyclines

Tetracyclines, like doxycycline, may cause photosensitivity and are contraindicated in children and pregnant women due to effects on bone and teeth, but they are not linked to tendon damage.

D. Cephalosporins

Cephalosporins are generally well tolerated and are not associated with tendonitis or tendon rupture. They do not have this black box warning.

Correct Answer: A. Second generation antipsychotics have a reduced risk of causing EPS

Explanation:

Antipsychotic medications are commonly classified into two categories: first-generation antipsychotics (FGA) and second-generation antipsychotics (SGA). These classes have distinct profiles, particularly when it comes to side effects such as extrapyramidal symptoms (EPS) and metabolic syndrome.

A. Second generation antipsychotics have a reduced risk of causing EPS

This statement is correct. Second-generation antipsychotics (SGAs), also known as atypical antipsychotics, generally have a lower risk of causing extrapyramidal symptoms (EPS) compared to first-generation antipsychotics (FGAs). EPS includes symptoms such as tremors, rigidity, and bradykinesia, which are commonly seen with older, first-generation antipsychotics like haloperidol. Second-generation antipsychotics such as clozapine, olanzapine, and risperidone tend to cause fewer motor side effects, making them more favorable in terms of movement disorders.

Why the Other Options Are Incorrect:

B. First generation antipsychotics are more effective for negative symptoms

This statement is incorrect. First-generation antipsychotics (FGAs) are generally more effective at treating positive symptoms of schizophrenia, such as hallucinations and delusions, but are less effective in managing negative symptoms like social withdrawal, anhedonia, and flat affect. Second-generation antipsychotics (SGAs) are typically more effective for treating both positive and negative symptoms of schizophrenia. They work on a broader range of symptoms, making them a preferred option for many patients.

C. There are no differences between these two classes

This statement is incorrect. There are significant differences between first-generation (FGA) and second-generation antipsychotics (SGA). While both classes are used to treat schizophrenia and bipolar disorder, their side effect profiles and mechanisms of action differ. SGAs generally have a lower risk of EPS, but they may be associated with a higher risk of metabolic syndrome (e.g., weight gain, diabetes, dyslipidemia). In contrast, FGAs are more likely to cause EPS but have a lower risk of metabolic side effects.

D. First generation antipsychotics have an increased risk of causing metabolic syndrome

This statement is incorrect. While second-generation antipsychotics (SGAs) are more commonly associated with an increased risk of metabolic syndrome, including weight gain, diabetes, and dyslipidemia, first-generation antipsychotics (FGAs) are generally less likely to cause these metabolic side effects. SGAs such as clozapine and olanzapine are particularly notorious for their metabolic effects, whereas FGAs tend to be more associated with motor-related side effects like EPS.

Correct Answer: A. Losartan

Explanation:

When treating hypertension in an otherwise healthy patient, angiotensin II receptor blockers (ARBs), such as Losartan, are considered first-line therapy. ARBs are commonly prescribed due to their ability to block the effects of angiotensin II, a potent vasoconstrictor that increases blood pressure. By inhibiting this pathway, Losartan helps to lower blood pressure, promote vasodilation, and reduce the workload on the heart without causing significant side effects commonly associated with other antihypertensive medications.

Why the Other Options Are Incorrect:

B. Metoprolol

Metoprolol, a beta-blocker, is not typically used as a first-line agent for hypertension in an otherwise healthy individual unless there are indications such as heart failure, arrhythmias, or a history of myocardial infarction. Beta-blockers work by blocking the beta-adrenergic receptors in the heart, which slows the heart rate and reduces blood pressure. However, they are not as effective as ARBs or ACE inhibitors for initial treatment of primary hypertension in patients without comorbidities.

C. Furosemide

Furosemide is a loop diuretic, and while it can be used to treat hypertension, especially in patients with fluid overload or heart failure, it is not a first-line agent for primary hypertension in a healthy individual. Diuretics, such as thiazide diuretics, are often used as first-line therapy in some cases of hypertension, but loop diuretics like furosemide are typically reserved for more severe cases or those involving conditions like edema or renal insufficiency

D. Spironolactone

Spironolactone is a potassium-sparing diuretic that works by inhibiting aldosterone, a hormone that promotes sodium and water retention. While it can be effective in treating hypertension and is sometimes used in resistant hypertension, it is not typically first-line therapy. It may be prescribed when a patient has secondary causes of hypertension, such as hyperaldosteronism, or in cases of heart failure or chronic kidney disease.